Home › Sickle Cell Disease

Sickle Cell Disease clinical trials recruiting in the U.S.

107 studies for Sickle Cell Disease are recruiting participants at sites across the United States.

Sickle cell disease is a group of inherited disorders that affect your red blood cells. It can cause pain, anemia, and other problems. Learn about treatments.

Cities with the most studies

• Atlanta, GA22 studies
• Washington, DC20 studies
• Chicago, IL18 studies
• Memphis, TN18 studies
• Philadelphia, PA15 studies
• Birmingham, AL14 studies
• New York City, NY13 studies
• St. Louis, MO12 studies
• Boston, MA10 studies
• Durham, NC10 studies
• Cincinnati, OH10 studies
• Houston, TX10 studies
• Columbus, OH9 studies
• Greenville, NC9 studies
• Pittsburgh, PA9 studies
• The Bronx, NY8 studies
• Oakland, CA7 studies
• Baltimore, MD7 studies
• Charlotte, NC7 studies
• Cleveland, OH7 studies
• Los Angeles, CA7 studies
• Nashville, TN6 studies
• Richmond, VA6 studies
• Hartford, CT5 studies
• Detroit, MI5 studies
• Jackson, MS5 studies
• Phoenix, AZ5 studies
• Indianapolis, IN5 studies
• Augusta, GA5 studies
• New Haven, CT4 studies
• Greenville, SC4 studies
• Arlington, VA4 studies
• New Orleans, LA4 studies
• Milwaukee, WI4 studies
• Edison, NJ3 studies
• Mobile, AL3 studies
• Minneapolis, MN3 studies
• Hollywood, FL3 studies
• Little Rock, AR3 studies
• Winston-Salem, NC3 studies

By state

• Alabama16 studies
• Arizona5 studies
• Arkansas3 studies
• California18 studies
• Connecticut7 studies
• Delaware6 studies
• District of Columbia10 studies
• Florida9 studies
• Georgia25 studies
• Illinois19 studies
• Indiana5 studies
• Louisiana5 studies
• Maryland17 studies
• Massachusetts10 studies
• Michigan9 studies
• Minnesota5 studies
• Mississippi5 studies
• Missouri13 studies
• New Jersey8 studies
• New York21 studies
• North Carolina18 studies
• Ohio22 studies
• Pennsylvania20 studies
• South Carolina6 studies
• Tennessee22 studies
• Texas11 studies
• Virginia9 studies
• Wisconsin4 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.